Market Overview

Steve Madden Falls 8%, Wunderlich Lowers Price Target


Wunderlich Securities lowered its price target on Steve Madden, Ltd. (NASDAQ: SHOO) from $43 to $39 in a report issued Monday. The firm reiterated its Buy rating.

Analyst Danielle McCoy lowered "FY14 and FY15 estimates to $1.83 (from $2.04) and $2.16 (from $2.42), respectively, after Steven Madden (SHOO) pre-announced weaker than expected 3Q results and became even more conservative in its FY14 outlook, reducing annual top- and bottom-line guidance."

McCoy believed "Steve Madden's diversified model remains in tact and that management is taking the necessary precautions to best battle the weak retail environment while at the same time positioning the business for long-term growth. Our revised price target of $39 maintains our previous valuation of 16x forward EPS."

The report concluded that peers are "currently trading 12.5x forward EPS vs. SHOO at 11x, and are currently being valued at a premium to SHOO due to greater growth rates off of lower bases. That said, SHOO is an attractive long-term story with a solid operating platform, ample cash balance and multiple global growth opportunities on tap."

Steve Madden, Ltd. recently traded at $29.08, down 8.9 percent.

Latest Ratings for SHOO

May 2019DowngradesOverweightNeutral
Jan 2019DowngradesOutperformMarket Perform
Dec 2018DowngradesBuyNeutral

View More Analyst Ratings for SHOO
View the Latest Analyst Ratings

Posted-In: Danielle McCoy WunderlichAnalyst Color Price Target Analyst Ratings


Related Articles (SHOO)

View Comments and Join the Discussion!

Latest Ratings

REALDA DavidsonInitiates Coverage On22.0
RVLVDA DavidsonInitiates Coverage On19.0
SFIXDA DavidsonInitiates Coverage On27.0
PENNJP MorganMaintains29.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Multiple Analysts Bullish On Vitae Pharmaceuticals Following End Of Lock-Up Period

Gannett Jumps On Upbeat Earnings; IBM Shares Slide